Latest filing published 26 Jan 2011 for VIROPRO INC.
Insider track record
No signal scores available.
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -41.0%Entry US$0.06 · Close at T+365 US$0.04
- +223.5%Entry US$0.02 · Close at T+365 US$0.05
- +366.0%Entry US$0.01 · Close at T+365 US$0.07
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Serge Beausoleil: trading record in brief
All filings by Serge Beausoleil on record concern Viropro Inc. Between 23 April 2010 and 5 January 2011, the trades on record add up to 20 filings.
In open-market terms, that means 13 purchases worth €196k on one side and 7 sales worth €193k on the other. No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2011: 3 purchases and 2 sales on the market.
In size, the median ticket on the buying side is €1,834. For 8 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -50.0%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 26 January 2011, reports an open-market sale of €150k in Viropro Inc. The most recent open-market purchase was published on 26 January 2011, 5,766 days ago. The median gap between a trade and its publication by SEC (Form 4) is 11 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Serge Beausoleil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500,000 shares0Common sharesSEC:0001096906-11-000121:2Canonical exit: 5 Apr 2011 (T+90)
- 4,500,000 shares@ US$0.0445Common sharesSEC:0001096906-11-000054:0Canonical exit: 5 Apr 2011 (T+90)
- 1,662,500 shares@ US$0.025Common sharesSEC:0001096906-11-000054:1Canonical exit: 5 Apr 2011 (T+90)
- 20,000 shares@ US$0.023Common sharesSEC:0001096906-10-000937:0
- 2,500,000 shares0VIROPRO COMMON SHARESSEC:0001096906-10-000752:0Canonical exit: 26 Aug 2010 (T+90)
- 245,800 shares@ US$0.02Common sharesSEC:0001096906-10-000602:0Canonical exit: 26 Jul 2010 (T+90)
- 174,200 shares@ US$0.02Common sharesSEC:0001096906-10-000602:1Canonical exit: 27 Jul 2010 (T+90)
- 200,000 shares@ US$0.02Common sharesSEC:0001096906-10-000602:2Canonical exit: 1 Aug 2010 (T+90)
- 117,500 shares@ US$0.02Common sharesSEC:0001096906-10-000602:3Canonical exit: 2 Aug 2010 (T+90)
- 25,000 shares@ US$0.03Common sharesSEC:0001096906-10-000503:0Canonical exit: 22 Jul 2010 (T+90)
- 25,400 shares@ US$0.025Common sharesSEC:0001096906-10-000503:1Canonical exit: 25 Jul 2010 (T+90)
- 5,000 shares@ US$0.023Common sharesSEC:0001096906-10-000503:2Canonical exit: 25 Jul 2010 (T+90)
- 25,000 shares@ US$0.022Common sharesSEC:0001096906-10-000503:3Canonical exit: 25 Jul 2010 (T+90)
- 100,000 shares@ US$0.02Common sharesSEC:0001096906-10-000503:4Canonical exit: 26 Jul 2010 (T+90)
14 of 14 declarations